Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US

Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US
Health experts are concerned by the simultaneous spread of three respiratory illnesses in the United States. (Photo: Getty)
Dan Brunskill
Fisher & Paykel Healthcare has reported half-year earnings ahead of analyst expectations and their own market guidance, with operating revenue at $690.6 million.The company had told the market to expect revenue to be $670m in its August trading update, warning that many customers were already stocked up on hospital products.Even though the higher-than-expected revenue was 23% lower than in the first half of the prior year, it was a 21% increase on the pre-pandemic period first half of 2020.Fisher & Paykel Healthcare's (FPH) chief ex...

More Markets

NZ sharemarket declined almost 2% this week
Markets Market close

NZ sharemarket declined almost 2% this week

The S&P/NZX 50 Index closed at 12,809.59 points, down 87.36 points or 0.68%.

Graham Skellern 06 Dec 2024
Updated: Methanex paid $200m to idle operations
Markets

Updated: Methanex paid $200m to idle operations

Genesis and Contact forked out millions to keep the lights on.

Ian Llewellyn 06 Dec 2024
THL slashes about 100 jobs
Markets

THL slashes about 100 jobs

THL is targeting a $12m after-tax profit cost savings in the 2027 financial year.

John Anthony 06 Dec 2024
Fonterra comfortable with co-op's margins
Primary Sector

Fonterra comfortable with co-op's margins

An extra $500 million is set to be paid out to its farmers from January.

Riley Kennedy 06 Dec 2024